|
National Research Corporation (NRC) DCF Valuation
US | Healthcare | Medical - Healthcare Information Services | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
National Research Corporation (NRC) Bundle
Enhance your investment strategies with the (NRC) DCF Calculator! Dive into authentic National Research Corporation financial data, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of (NRC).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 128.0 | 133.3 | 148.0 | 151.6 | 148.6 | 154.4 | 160.4 | 166.7 | 173.2 | 179.9 |
| Revenue Growth, % | 0 | 4.14 | 11.01 | 2.44 | -1.97 | 3.91 | 3.91 | 3.91 | 3.91 | 3.91 |
| EBITDA | 48.1 | 50.8 | 56.7 | 51.8 | 46.0 | 55.3 | 57.5 | 59.7 | 62.1 | 64.5 |
| EBITDA, % | 37.62 | 38.1 | 38.3 | 34.2 | 30.95 | 35.83 | 35.83 | 35.83 | 35.83 | 35.83 |
| Depreciation | 5.5 | 7.5 | 6.4 | 5.3 | 5.9 | 6.7 | 7.0 | 7.2 | 7.5 | 7.8 |
| Depreciation, % | 4.33 | 5.63 | 4.31 | 3.48 | 3.97 | 4.34 | 4.34 | 4.34 | 4.34 | 4.34 |
| EBIT | 42.6 | 43.3 | 50.3 | 46.6 | 40.1 | 48.6 | 50.5 | 52.5 | 54.5 | 56.7 |
| EBIT, % | 33.29 | 32.47 | 33.99 | 30.72 | 26.98 | 31.49 | 31.49 | 31.49 | 31.49 | 31.49 |
| Total Cash | 13.5 | 34.7 | 54.4 | 25.0 | 6.7 | 29.1 | 30.3 | 31.4 | 32.7 | 33.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 11.7 | 14.2 | 13.8 | 14.6 | 12.5 | 14.6 | 15.1 | 15.7 | 16.3 | 17.0 |
| Account Receivables, % | 9.17 | 10.68 | 9.35 | 9.61 | 8.39 | 9.44 | 9.44 | 9.44 | 9.44 | 9.44 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.000000781 | 0 | 0.000000676 | 0 | 0 | 0.000000291 | 0.000000291 | 0.000000291 | 0.000000291 | 0.000000291 |
| Accounts Payable | 1.3 | 1.1 | 1.9 | 1.2 | 1.3 | 1.5 | 1.5 | 1.6 | 1.7 | 1.7 |
| Accounts Payable, % | 0.99936 | 0.8216 | 1.31 | 0.76071 | 0.87562 | 0.95411 | 0.95411 | 0.95411 | 0.95411 | 0.95411 |
| Capital Expenditure | -4.7 | -4.0 | -5.5 | -9.8 | -15.8 | -8.5 | -8.8 | -9.2 | -9.5 | -9.9 |
| Capital Expenditure, % | -3.64 | -2.99 | -3.73 | -6.49 | -10.62 | -5.49 | -5.49 | -5.49 | -5.49 | -5.49 |
| Tax Rate, % | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 |
| EBITAT | 34.1 | 38.9 | 38.8 | 34.6 | 31.1 | 38.8 | 40.3 | 41.8 | 43.5 | 45.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 24.5 | 39.7 | 40.9 | 28.5 | 23.4 | 35.1 | 37.9 | 39.4 | 40.9 | 42.5 |
| WACC, % | 6.29 | 6.32 | 6.27 | 6.26 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 162.8 | |||||||||
| Long Term Growth Rate, % | 0.50 | |||||||||
| Free cash flow (T + 1) | 43 | |||||||||
| Terminal Value | 739 | |||||||||
| Present Terminal Value | 545 | |||||||||
| Enterprise Value | 708 | |||||||||
| Net Debt | 32 | |||||||||
| Equity Value | 675 | |||||||||
| Diluted Shares Outstanding, MM | 25 | |||||||||
| Equity Value Per Share | 27.38 |
What You Will Get
- Real NRC Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Evaluate various scenarios to assess NRC’s future performance.
- User-Friendly Design: Designed for professionals while remaining easy to use for newcomers.
Key Features
- Comprehensive NRC Data: Pre-loaded with National Research Corporation’s historical performance metrics and future forecasts.
- Customizable Assumptions: Modify growth rates, profit margins, discount rates, tax assumptions, and capital investments.
- Interactive Valuation Framework: Real-time updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
- User-Centric Interface: Intuitive, organized, and suitable for both seasoned professionals and newcomers.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered NRC data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for NRC’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for National Research Corporation (NRC)?
- Reliable Data: Utilize authentic National Research Corporation financials for trustworthy valuation outcomes.
- Tailorable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Efficient: Built-in calculations save you from the hassle of starting from the ground up.
- Expert-Level Tool: Crafted for investors, analysts, and consultants focused on NRC.
- Easy to Use: User-friendly design and guided instructions ensure accessibility for everyone.
Who Should Use This Product?
- Investors: Accurately assess National Research Corporation’s (NRC) fair value prior to investment decisions.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to NRC.
- Consultants: Easily customize the template for valuation reports tailored to NRC clients.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading research firms.
- Educators: Employ it as a teaching resource to illustrate valuation methodologies relevant to NRC.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for National Research Corporation (NRC).
- Real-World Data: Historical and projected financials for NRC preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into NRC's performance.
- Key Ratios: Integrated analysis for evaluating profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Visualizations including charts and tables for clear, actionable findings.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.